Found: 46
Select item for more details and to access through your institution.
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01164-x
- By:
- Publication type:
- Article
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2
- By:
- Publication type:
- Article
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00985-0
- By:
- Publication type:
- Article
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00978-z
- By:
- Publication type:
- Article
MRD negativity: considerations for older adults with multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00939-y
- By:
- Publication type:
- Article
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00905-8
- By:
- Publication type:
- Article
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00888-6
- By:
- Publication type:
- Article
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00883-x
- By:
- Publication type:
- Article
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 5, p. 1, doi. 10.1007/s00520-023-07717-3
- By:
- Publication type:
- Article
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1575, doi. 10.3390/curroncol29030132
- By:
- Publication type:
- Article
Quality of end‐of‐life care in multiple myeloma: A 13‐year analysis of a population‐based cohort in Ontario, Canada.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 5, p. 688, doi. 10.1111/bjh.18401
- By:
- Publication type:
- Article
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 93, doi. 10.1111/bjh.18172
- By:
- Publication type:
- Article
Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2249, doi. 10.1002/ajh.27473
- By:
- Publication type:
- Article
Still high risk? A review of translocation t(14;16) in multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 10, p. 1979, doi. 10.1002/ajh.27419
- By:
- Publication type:
- Article
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population‐based cohort study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. E197, doi. 10.1002/ajh.26957
- By:
- Publication type:
- Article
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world".
- Published in:
- Annals of Hematology, 2021, v. 100, n. 5, p. 1261, doi. 10.1007/s00277-021-04420-3
- By:
- Publication type:
- Article
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad100
- By:
- Publication type:
- Article
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 815, doi. 10.1111/ejh.14082
- By:
- Publication type:
- Article
Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 626, doi. 10.1111/ejh.13496
- By:
- Publication type:
- Article
Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4357, doi. 10.1002/cam4.5245
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.826342
- By:
- Publication type:
- Article
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. e227, doi. 10.1016/j.clml.2024.02.006
- By:
- Publication type:
- Article
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 340, doi. 10.1016/j.clml.2023.01.016
- By:
- Publication type:
- Article
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 608, doi. 10.1016/j.clml.2022.03.002
- By:
- Publication type:
- Article
P-222: Extended follow-up safety and efficacy results of Belantamab mafodotin (Belamaf) 1.92 mg/kg or 2.5 mg/kg combined with POM and DEX for the treatment of relapsed/refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S162, doi. 10.1016/S2152-2650(21)02349-1
- By:
- Publication type:
- Article
Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e714, doi. 10.1016/j.clml.2021.05.002
- By:
- Publication type:
- Article
Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Quality of Life Assessment in Older Patients with Newly-Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e232, doi. 10.1016/j.clml.2019.09.386
- By:
- Publication type:
- Article
Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient-Reported Outcome Measures in Cancer Care: An Updated Systematic Review and Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2424793, doi. 10.1001/jamanetworkopen.2024.24793
- By:
- Publication type:
- Article
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00843-5
- By:
- Publication type:
- Article
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00843-5
- By:
- Publication type:
- Article
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00779-2
- By:
- Publication type:
- Article
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00769-4
- By:
- Publication type:
- Article
Financial toxicity in hematological malignancies: a systematic review.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00671-z
- By:
- Publication type:
- Article
Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149830
- By:
- Publication type:
- Article
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 519, doi. 10.1093/oncolo/oyae041
- By:
- Publication type:
- Article
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.974038
- By:
- Publication type:
- Article
Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?
- Published in:
- Drugs & Aging, 2018, v. 35, n. 4, p. 289, doi. 10.1007/s40266-018-0539-1
- By:
- Publication type:
- Article
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778
- By:
- Publication type:
- Article
Venous thrombosis in inflammatory bowel disease.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 474, doi. 10.1002/jha2.894
- By:
- Publication type:
- Article
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1252, doi. 10.1002/jha2.559
- By:
- Publication type:
- Article
Gender disparities in multiple myeloma publications.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 966, doi. 10.1002/jha2.470
- By:
- Publication type:
- Article